Leyla HAZAR, Mine KARAHAN, Mehmet Emin DURSUN, Sedat AVA, Seyfettin ERDEM, Esra VURAL, Uğur KEKLİKÇİ

İntravitreal Bevacizumab ile Tedavi Edilen Prematüre Retinopatili Bebeklerde Risk Faktörlerinin Değerlendirilmesi

Amaç: Prematüre retinopatisi (PR) olgularında retinopatinin şiddeti ile anne ve bebekteki risk faktörlerinin ilişkisini analiz etmekYöntemler: Haziran 2017- Ekim 2020 yılları arasında Dicle Üniversitesi Tıp Fakültesinde prematüre retinopatisi nedeniyle takip edilen bebeklerin verileri retrospektif olarak değerlendirildi. Prematüre bebeklerin, doğum yaşı, doğum ağırlığı, takip süresince eşlik eden komorbid hastalıklar, annenin gebelik problemleri kaydedildi. Tedavisiz takip edilenler (grup 1) ve intravitreal bevacizumab tedavisi uygulananlar (grup 2) karşılaştırıldı.Sonuçlar: Çalışmaya 167 prematüre bebek alındı. Prematüre bebeklerin 99’unda (%60) tedavi gerektirmeyen PR vardı (grup 1), 68’ine (%40) intravitreal bevacizumab (grup 2) uygulandı. Grup 2’nin gestasyonel yaşı ve doğum ağırlığı grup 1’den anlamlı olarak düşük iken (p

Evaluation of Risk Factors in Infants with Premature Retinopathy Treated with Intravitreal Bevacizumab

Objective: To analyze the relationship between the severity of retinopathy in premature infants and risk factors in the mother and infant. Methods: The medical records of the infants who were followed up at Dicle University Faculty of Medicine due to retinopathy of premature (ROP) between June 2017 and October 2020 were retrospectively evaluated. Birth age, birth weight, accompanying comorbid diseases during the follow-up period, and pregnancy problems of the mother were recorded. Those who were followed up without treatment (group 1) and those who received intravitreal bevacizumab treatment (group 2) were compared. Results: One hundred sixty seven premature infants were included in the study. Ninety nine of them (60%) had ROP that did not require treatment (group 1), 68 (40%) were administered intravitreal bevacizumab (group 2). While the gestational age and birth weight of group 2 were significantly lower than group 1 (p

PDF

___

1. Goktas A, Sener EC, Sanac AS. An assessment of ocular morbidities of children born prematurely in early childhood. J Pediatr Ophthalmol Strabismus. 2012; 49: 236–41.
2. Gilbert C, Fielder A, Gordillo L, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005; 115: e518– 25.
3. Akkoyun, İ. Prematüre Retinopatisinin Patofizyolojisi. Turk J Ophthalmol, 2012; 42: 63-7. 4. Martin RJ, Fanaroff AA, Walsh MC, Fanaroff and Martin’s neonatal perinatal medicine: diseases of the fetus and infant. Philadelphia: Elsevier Saunders, 2015: 1767–4.
5. Bas AY, Demirel N, Koc E, et al. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units. Br J Ophthalmol. 2018; 102: 1711-16.
6. Wikstrand MH, Hard AL, Niklasson A, et al. Maternal and neonatal factors associated with poor early weight gain and later retinopathy of prematurity. Acta Paediatr. 2011; 100:1528–33.
7. Dwivedi A, Dwivedi D, Lakhtakia S, et al. Prevalence, risk factors and pattern of severe retinopathy of prematurity in eastern Madhya Pradesh. Indian J Ophthalmol. 2019; 67: 819–23.
8. Zhu Z, Hua X, Yu Y, et al. Effect of red blood cell transfusion on the development of retinopathy of prematurity: A systematic review and metaanalysis. PLoS One. 2020; 15: e0234266.
9. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123: 991-9.
10. Early Treatment for Retinopathy of Prematurity Cooperative Group, Results of the early treatment for retinopathy of prematurity randomized trial: revised indications for the treatment of retinopathy of prematurity, Arch Ophthalmol. 2003; 121: 1684- 96.
11. Kavurt S, Yücel H, Hekimoğlu E, et al. Prematüre retinopatisi gelişen olgularda risk faktörlerinin değerlendirilmesi. Çocuk Sağlığı ve Hastalıkları Dergisi 2012; 55: 125-31.
12. Tunay ZÖ, Özdemir Ö, Acar DE, et al. Maternal diabetes as an independent risk factor for retinopathy of prematurity in infants with birth weight of 1500 g or more. Am J of Ophthalmol 2016; 168: 201- 6.
13. Dai AI, Demiryürek S, Aksoy SN, et al. Maternal iron deficiency anemia as a risk factor for the development of retinopathy of prematurity. Pediatric Neurology 2015; 53: 146-50.
14. Zhu TT, Zhang L, Zhao FY, et al. Association of maternal hypertensive disorders with retinopathy of prematurity: A systematic review and metaanalysis. PLoS ONE 2017; 12: e0175374.
15. Yu XD, Branch DW, Karumanchi SA, et al. Preeclampsia and retinopathy of prematurity in preterm births. Pediatrics. 2012; 130: e101–7.
16. Hong HK, Lee HJ, Ko JH, et al. Neonatal systemic inflammation in rats alters retinal vessel development and simulates pathologic features of retinopathy of prematurity. J Neuroinflammation. 2014; 11: 1-10.
17. Woo SJ, Park KH, Jung HJ, et al. Effects of maternal and placental inflammation on retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2012; 250: 915-23.
18. Villamor-Martinez E, Cavallaro G, Raffaeli G, et al. Chorioamnionitis as a risk factor for retinopathy of prematurity: An updated systematic review and meta-analysis. PloS one, 2018;13: e0205838.
19. Mitra S, Aune D, Speer CP, et al. Chorioamnionitis as a risk factor for retinopathy of prematurity: a systematic review and meta-analysis. Neonatology. 2014; 105:189–99.
20. Ozdemır R, Sarı FN, Tunay ZO, et al. The association between respiratory tract Ureaplasma urealyticum colonization and severe retinopathy of prematurity in preterm infants ≤1250 g. Eye (Lond). 2012; 26: 992–6.
21. Lynch AM, Wagner BD, Hodges JK, et al. The relationship of the subtypes of preterm birth with retinopathy of prematurity. Am J Obstet Gynecol. 2017; 217: 354-e1.
22. Ünsal AİA, Sezer SD, Güler D, et al. Maternal faktörlerin Prematür Retinopatisi gelişimindeki olası rolü. Pam Tıp Der, 2019; 12: 569-75.
23. Sood V, Chellani H, Arya S, et al. Changing spectrum of retinopathy of prematurity (ROP) and variations among siblings of multiple gestation. Indian J Pediatr. 2012; 79:905-10.
24. Conde-Agudelo A, Romero R, Hassan SS, et al. Transvaginal sonographic cervical length for the prediction of spontaneous preterm birth in twin pregnancies: a systematic review and metaanalysis. Am J Obstet Gynecol 2010; 203: 128 e1e12.
25. Şekeroğlu MA, Hekimoğlu E, Çelik Ü, et al. Üçüz Bebeklerde Prematüre Retinopatisi. Turk J Ophthalmol, 2016; 46: 114-7.
26. Hellstro¨m A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013; 382: 1445–57.
27. Park SH, Yum HR, Kim S, et al. Retinopathy of prematurity in Korean infants with birthweight greater than 1500 g. Br J Ophthalmol. 2016; 100: 834-8.
28. Oyur G, Hazar L, Vural E, et al. Evaluation of Retinopathy Severity According to the Premature Stage in Premature Retinopathy. Van Med J, 2019; 27: 139-43.
29. Sukgen EA, Koçluk Y, Mert K. Büyük Prematüre Bebekler Ağır Retinopati ile Karşı Karşıya. Ret-Vit 2018; 27: 43-7.